Barry J. Potter, Jia‐Zhang Ni, Kathleen Wolfe, Decherd Stump, Paul D. Berk – 1 October 1994 – To determine whether phenobarbital affects hepatocellular bilirubin/sulfobromophthalein uptake mechanism, we administered it to male Sprague‐Dawley rats, body weight 175 ± 25 gm, at doses of 1 to 75 mg/kg body wt/day for 7 days. Control rats were given an equivalent volume of physiological saline solution.

Maria Giulia Battelli, Laura Buonamici, Andrea Bolognesi, Fiorenzo Stirpe – 1 October 1994 – A Ber‐H2/saporin immunotoxin, consisting of the single‐chain ribosome‐inactivating protein saporin‐S6 and the anti‐CD30 monoclonal antibody Ber‐H2, gave encouraging results in the treatment of refractory Hodgkin's disease but caused a transient hepatotoxicity. The accumulation of Ber‐H2/saporin conjugate and of its components by rat liver parenchymal and nonparenchymal cells was studied.

T. Jake Liang, M. Sawkat Anwer, Bruce R. Bacon, Henry C. Bodenheimer, James M. Crawford, Norman D. Grace, Sanjeev Gupta, Joel Lavine, Arun J. Sanyal – 1 October 1994 – One hundred patients underwent transjugular intrahepatic portosystemic shunt (TIPS) creation for variceal bleeding (n = 94), intractable ascites (n = 3), hepatorenal syndrome (n = 2), and preoperative portal decompression (n = 1). Shunts were completed in 96 patients.

Paolo Angeli, Wladimiro Jiménez, Vicente Arroyo, Harald S. Mackenzie, Ping L. Zhang, Joan Clária, Francisca Rivera, Barry M. Brenner, Joan Rodés – 1 October 1994 – The aim of this study was to assess the effect of HS‐142‐1, a recently discovered specific antagonist of endogenous natriuretic peptides, on systemic hemodynamics, renal function, and the renin‐aldosterone system in rats with cirrhosis and ascites. The study consisted of three protocols, each including 10 conscious control rats and 10 conscious rats with carbontetrachloride‐induced cirrhosis with ascites.

Raymond S. Koff, Kevin D. Mullen – 1 October 1994

María Cascales, Alberto Alvarez, Pilar Gascó, Lourdes Fernández‐Simón, Nuria Sanz, Lisardo Boscá – 1 October 1994 – Liver injury was induced by a single dose (60 mg/kg) of cocaine in male albino Swiss mice untreated or pretreated with phenobarbital (in drinking water 1 gm/L), for 5 days before cocaine administration. One parameter of liver injury, serum isocitrate dehydrogenase activity, showed sharp increases at 24 hr of cocaine treatment; we also noted decreased hepatic levels of ATP, GSH, cytochrome P‐450 and NADPH/NADP+ ratio and increases in malondialdehyde concentration.

Yuji Tanaka, Norio Hayashi, Akira Kaneko, Toshifumi Ito, Masayoshi Horimoto, Yutaka Sasaki, Akinori Kasahara, Hideyuki Fusamoto, Takenobu Kamada – 1 October 1994 – To investigate the signaling pathways to Na+/H+ exchanger activation with epidermal growth factor in hepatocytes, we measured changes in cytosolic free calcium and intracellular pH levels at the single‐cell level using digital imaging fluorescence microscopy of fura‐2—or BCECF‐loaded hepatocytes in primary culture.

Elena Vara, Javier Arias‐Díaz, Juan Torres‐Melero, Cruz García, José M. Rodríguez, José L. Balibrea – 1 October 1994 – Cytokines seem to play an important role in the metabolic disturbances that are commonly associated with sepsis. In this study, we analyzed the effect of tumor necrosis factor, interleukin‐1 and interleukin‐6, as well as that of tumor necrosis factor in combination with interleukin‐1 or interleukin‐6, both on free fatty acids and on phospholipid synthesis by isolated rat hepatocytes.

Koichi Tsuneyama, Judy Van De Water, Yasuni Nakanuma, Sanghoon Cha, Aftab Ansari, Ross Coppel, M. Eric Gershwin – 1 October 1994 – An increase in the incidence of Sjögren's syndrome in patients with primary biliary cirrhosis has been noted. Indeed, primary biliary cirrhosis has been described as a ductal disease with involvement not only of the biliary tract but of epithelial ductal cells in other organs. We have previously reported the development of a panel of mouse monoclonal antibodies directed at PDC‐E2, the major autoantigen of primary biliary cirrhosis.

Hanns‐Ulrich Marschall, William James Griffiths, Ulrich Götze, Jie Zhang, Hubertus Wietholtz, Norbert Busch, Jan Sjövall, Siegfried Matern – 1 October 1994 – Ursodeoxycholic acid (750 mg/day) was administered orally to ten healthy subjects over a period of 10 days; 24 hr urine samples were collected the day before and on the last day of the study. Urinary bile acids were extracted, separated into groups of conjugates and analyzed by gas chromatography‐mass spectrometry and fast atom bombardment mass spectrometry. Excretion of ursodeoxycholic acid rose from 70 to 2,915 μg/24 h.